Pronađeno: 51-60 / 242 radova

Autori: Potpara Tatjana S

>> Prikaži sve rezultate

Naslov ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up (Article)
Autori Baigent Colin  ...  Polovina Marija M  Potpara Tatjana S  ...  Seferovic Petar M  ...  (broj koautora 67) 
Info CARDIOVASCULAR RESEARCH, (2022), vol. 118 br. 7, str. 1618-1666
Projekat Bernard Iung (France); Raffaele Piccolo (Italy); National Cancer Institute. Matthieu Depuydt European Society of Cardiology
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis (Article)
Autori Baigent Colin  ...  Polovina Marija M  Potpara Tatjana S  ...  Seferovic Petar M  ...  (broj koautora 67) 
Info CARDIOVASCULAR RESEARCH, (2022), vol. 118 br. 6, str. 1385-1412
Projekat National Cancer Institute
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry (Article)
Autori Ding Wern Yew  Proietti Marco  Boriani Giuseppe  Fauchier Laurent  Blomstrom-Lundqvist Carina  Marin Francisco  Potpara Tatjana S  Lip Gregory YH 
Info EUROPACE, (2022), vol. 24 br. 5, str. 721-728
Projekat Abbott Vascular IntAbbott Laboratories; Amgen Cardiovascular; AstraZenecaAstraZeneca; BayerBayer AG; Boehringer IngelheimBoehringer Ingelheim; Boston ScientificBoston Scientific; Bristol Myers SquibbBristol-Myers Squibb; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and CompanyEli Lilly; Edwards [2016-19]; Gedeon Richter Plc.; Menarini Int. Op.Menarini Group; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIERServier; Vifor; Pfizer Alliance
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society (Article)
Autori Gorog Diana A  ...  Potpara Tatjana S  ...  (broj koautora 17) 
Info EUROPACE, (2022), vol. 24 br. 11, str. 1844-1871
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry (Article)
Autori Malavasi Vincenzo L  Vitolo Marco  Proietti Marco  Diemberger Igor  Fauchier Laurent  Marin Francisco  Nabauer Michael  Potpara Tatjana S  Dan Gheorghe-Andrei  Kalarus Zbigniew  Tavazzi Luigi  Maggioni Aldo Pietro  Lane Deirdre A  Lip Gregory YH  Boriani Giuseppe 
Info EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, (2022), vol. 52 br. 7, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry (Article)
Autori Miguel Rivera-Caravaca Jose  ...  Potpara Tatjana S  ...  (broj koautora 17) 
Info EUROPACE, (2022), vol. 24 br. 2, str. 202-210
Projekat Abbott Vascular Int.Abbott Laboratories; Amgen Cardiovascular; AstraZenecaAstraZeneca; Bayer AGBayer AG; Boehringer IngelheimBoehringer Ingelheim; Boston ScientificBoston Scientific; The Bristol Myers SquibbBristol-Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and CompanyEli Lilly; Edwards; Gedeon Richter Plc.; Menarini Int. Op.Menarini Group; MSDMerck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIERServier; Bristol Myers Squibb/Pfizer Alliance; German Centre for Cardiovascular Research (DZHK); BMS-Pfizer Alliance; Daiichi-SankyoDaiichi Sankyo Company Limited; Boehringer-IngelheimBoehringer Ingelheim
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up (Article)
Autori Baigent Colin  ...  Polovina Marija M  Potpara Tatjana S  ...  Seferovic Petar M  ...  (broj koautora 67) 
Info EUROPEAN HEART JOURNAL, (2022), vol. 43 br. 11, str. 1059-1103
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis The Task Force for the management of COVID-19 of the European Society of Cardiology (Article)
Autori Baigent Colin  ...  Polovina Marija M  Potpara Tatjana S  ...  Seferovic Petar M  ...  (broj koautora 67) 
Info EUROPEAN HEART JOURNAL, (2022), vol. 43 br. 11, str. 1033-1058
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry (Article)
Autori Proietti Marco  Romiti Giulio Francesco  Vitolo Marco  Potpara Tatjana S  Boriani Giuseppe  Lip Gregory YH 
Info EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, (2022), vol. 8 br. 7, str. 778-786
Projekat Abbott Vascular International; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb; Pfizer Alliance; The Alliance Daiichi S
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry (Article)
Autori Ding Wern Yew  Potpara Tatjana S  Blomstrom-Lundqvist Carina  Boriani Giuseppe  Marin Francisco  Fauchier Laurent  Lip Gregory YH 
Info EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, (2022), vol. 52 br. 6, str. -
Projekat Abbott Laboratories; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb; Pfizer Alliance; Alliance Daiichi
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX